Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
AstraZeneca call volume above normal and directionally bullish
3d ago
AZN
Premium
Ratings
AstraZeneca’s Promising Pipeline and Valuation: A Compelling Investment Opportunity
3d ago
AZN
Premium
Ratings
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Clinical Success and Strategic Advantages
3d ago
AZN
Premium
The Fly
Personalis reports data from AstraZeneca phase 3 clinical trial in lung cancer
4d ago
AZN
PSNL
Premium
The Fly
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
5d ago
AZN
FGEN
Premium
Ratings
AstraZeneca’s Promising Non-Oncology Pipeline and Baxdrostat’s Market Potential Drive Buy Rating
5d ago
AZN
Premium
Company Announcements
AstraZeneca Announces Current Share Capital and Voting Rights
6d ago
Premium
Ratings
AstraZeneca: Strong Market Position and Growth Potential Justify Buy Rating
6d ago
AZN
Premium
Ratings
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Potential and Strategic Positioning
6d ago
AZN
Premium
The Fly
AstraZeneca reports baxdrostat met primary, secondary endpoints in Phase 3 trial
7d ago
AZN
Premium
Ratings
AstraZeneca’s Promising Hypertension Breakthrough: Analyst Recommends Buy Ahead of Phase III Data Presentation
9d ago
AZN
Premium
Company Announcements
AstraZeneca Clarifies TR-1 Notification Error
10d ago
Premium
Company Announcements
The Capital Group Adjusts AstraZeneca Holdings
17d ago
Premium
Company Announcements
AstraZeneca CFO Sells Company Shares
20d ago
Premium
The Fly
FibroGen announces approval for FibroGen China sale to AstraZeneca
20d ago
AZN
FGEN
Premium
The Fly
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
23d ago
AMD
AZN
Premium
The Fly
AstraZeneca announces Flumist availability for home delivery
23d ago
AZN
Premium
The Fly
Soros boosts exits stake in AstraZeneca, cuts position in Alphabet
23d ago
GS
SW
Premium
The Fly
Trump Trade: Pharma tariff announcement likely ‘weeks away’
24d ago
AZN
BMY
Premium
The Fly
Pharma tariff announcement likely ‘weeks away,’ Reuters reports
25d ago
AZN
BMY
Premium
The Fly
Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
30d ago
AZN
BMY
Premium
The Fly
Trump, pharma industry discuss increasing medicine spending abroad, Reuters says
30d ago
AZN
BMY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
